Nikolova Antonia, Milanov Ivan, Kmetska Ksenia
Department of Neurology, Medical University, Sofia, Bulgaria.
Multiprofile Hospital for Treatment in Neurology and Psychiatry, Sofia, Bulgaria.
Front Neurol. 2025 Mar 18;16:1513390. doi: 10.3389/fneur.2025.1513390. eCollection 2025.
Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune, demyelinating and neurodegenerative disease of the central nervous system that primarily affects young, active people and is a leading cause of non-traumatic, irreversible neurological deficit. Multiple sclerosis is one of the most studied diseases in neuroepidemiology and is characterized by an uneven geographical distribution worldwide.
To estimate the prevalence and incidence of multiple sclerosis in Bulgaria and their distribution by age and gender, using data from the latest population census in the country, provided by the National Statistical Institute.
An epidemiological study, covering a 7-year period-from 2015 to 2021 was conducted in Bulgaria. Eight regions with their population were included in the study-Blagoevgrad, Montana, Pernik, Svoge, Smolyan, Troyan, Haskovo and Shumen. Data, provided by the National Statistical Institute, were used to calculate the values of prevalence and incidence of multiple sclerosis. All cases were diagnosed using the 2017 McDonald's diagnostic criteria. The results obtained from the study were also used to determine the clinical characteristics of the Bulgarian patient. For the purposes of the epidemiological study an individual questionnaire was developed.
On the prevalence day-07.09.2021, there were 532 people with multiple sclerosis in the studied regions of the country, revealing a prevalence of 121.2/100000 and an incidence of 4.2/100000. 182 of them were males and 350 were females comprising a ratio of 2:1 in favor of the women. More than 50% of all cases had relapsing-remitting course of disease. Secondary-progressive MS had 30% of all patients and 10% suffered from primary progressive multiple sclerosis. Clinically isolated syndrome was present in less than 5% of patients. The mean age at disease onset was 32.2 ± 10.3 years.
The established values of prevalence and incidence position Bulgaria in the area with a high frequency of MS. There is an increase in prevalence and incidence compared to previous studies conducted in the country. The results obtained are similar to those reported by the neighboring countries of the Balkan Peninsula and are close to the average values in Europe according to the latest edition of Atlas of Multiple Sclerosis.
多发性硬化症(MS)是一种慢性、炎症性、自身免疫性、脱髓鞘性和神经退行性中枢神经系统疾病,主要影响年轻、活跃人群,是导致非创伤性、不可逆神经功能缺损的主要原因之一。多发性硬化症是神经流行病学中研究最多的疾病之一,其特点是在全球范围内地理分布不均。
利用保加利亚国家统计局提供的该国最新人口普查数据,估算保加利亚多发性硬化症的患病率和发病率及其按年龄和性别的分布情况。
在保加利亚进行了一项为期7年(2015年至2021年)的流行病学研究。研究纳入了八个地区及其人口——布拉戈耶夫格勒、蒙塔纳、佩尔尼克、斯沃格、斯莫梁、特罗扬、哈斯科沃和舒门。利用国家统计局提供的数据计算多发性硬化症的患病率和发病率值。所有病例均根据2017年麦克唐纳诊断标准进行诊断。研究所得结果还用于确定保加利亚患者的临床特征。为进行流行病学研究,编制了一份个人问卷。
在患病率统计日(2021年9月7日),该国研究地区有532例多发性硬化症患者,患病率为121.2/100000,发病率为4.2/100000。其中男性182例,女性350例,男女比例为2:1,女性占优。所有病例中超过50%患有复发缓解型疾病。继发进展型MS占所有患者的30%,10%患有原发进展型多发性硬化症。临床孤立综合征患者不到5%。疾病发病的平均年龄为32.2±10.3岁。
所确定的患病率和发病率值使保加利亚处于多发性硬化症高发地区。与该国此前进行的研究相比,患病率和发病率有所上升。所得结果与巴尔干半岛邻国报告的结果相似,且根据最新版《多发性硬化症地图集》接近欧洲平均值。